Clinical Trials for Advanced Accelerator Applications

Explore 21 clinical trials worldwide

Showing 1-21 of 21 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Advanced Accelerator Applications

Clinical Trials (21)

NCT06783348
Radiopharmaceutical Treatment of Advanced Kidney Cancer
PHASE2Not yet recruiting
48 participants
Started: Oct 30, 2025 · Completed: Jan 1, 2029
1 condition2 sponsors0 locations
NCT04529044
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
PHASE2Not yet recruiting
10 participants
Started: Jan 1, 2025 · Completed: Dec 20, 2025
3 conditions4 sponsors1 location
NCT06388369
Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
PHASE1/PHASE2Not yet recruiting
58 participants
Started: May 31, 2024 · Completed: Sep 30, 2028
1 condition3 sponsors1 location
NCT05198479
Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in
PHASE2Recruiting
25 participants
Started: May 5, 2023 · Completed: Sep 30, 2025
1 condition3 sponsors2 locations
NCT03966651
A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.
PHASE1Recruiting
18 participants
Started: Apr 17, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors14 locations
NCT05885009
Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)
N/ARecruiting
240 participants
Started: Mar 28, 2023 · Completed: Mar 28, 2028
1 condition7 sponsors1 location
NCT05249114
Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors
PHASE1Active, not recruiting
6 participants
Started: Dec 28, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT04711135
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
PHASE2Active, not recruiting
11 participants
Started: Aug 31, 2022 · Completed: May 7, 2034
3 conditions1 sponsor7 locations
NCT05150236
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC
PHASE2Active, not recruiting
93 participants
Started: Apr 29, 2022 · Completed: Dec 31, 2024
7 conditions5 sponsors8 locations
NCT05178693
Lutathera and ASTX727 in Neuroendocrine Tumours
PHASE1Recruiting
27 participants
Started: Apr 25, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05162573
EBRT + Lu-PSMA for N1M0 Prostate Cancer
PHASE1Recruiting
24 participants
Started: Dec 20, 2021 · Completed: Jul 1, 2025
1 condition3 sponsors2 locations
NCT04837885
Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases
PHASE2Recruiting
23 participants
Started: Sep 24, 2021 · Completed: Mar 24, 2027
3 conditions2 sponsors4 locations
NCT04903899
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
PHASE2Recruiting
24 participants
Started: May 19, 2021 · Completed: May 20, 2031
2 conditions3 sponsors5 locations
NCT04727723
Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs
N/AActive, not recruiting
164 participants
Started: Mar 9, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor18 locations
NCT04443062
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer
PHASE2Active, not recruiting
58 participants
Started: Jul 20, 2020 · Completed: Jan 1, 2026
1 condition3 sponsors4 locations
NCT04375267
177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours
PHASE1Active, not recruiting
18 participants
Started: Apr 23, 2020 · Completed: Jun 30, 2024
4 conditions2 sponsors1 location
NCT04343885
In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy
PHASE2Active, not recruiting
130 participants
Started: Apr 21, 2020 · Completed: Mar 31, 2026
1 condition9 sponsors12 locations
NCT03972488
Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
PHASE3Active, not recruiting
226 participants
Started: Jan 8, 2020 · Completed: Oct 29, 2027
1 condition1 sponsor40 locations
NCT04069299
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract
N/AActive, not recruiting
30 participants
Started: Sep 25, 2019 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT03872778
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake
PHASE1/PHASE2Active, not recruiting
51 participants
Started: Jul 24, 2019 · Completed: Dec 1, 2026
1 condition1 sponsor11 locations
NCT03691064
Post-Authorization Long-Term Safety Study of LUTATHERA
N/AActive, not recruiting
1,014 participants
Started: Nov 28, 2018 · Completed: Jun 30, 2028
1 condition1 sponsor20 locations